Drug General Information (ID: D0741)
  Drug Name
Griseofulvin
  Drug Type Small molecule
  Drug Synonymous
Amudane; Delmofulvina; Fulcin; Fulcine; Fulvicin; FulvicinUF; Fulvina; Fulvinil; Fulvistatin; Fungivin; Greosin;Gresfeed; Gricin; Grifulin; Grifulvin; GrisPEG; Grisactin; Griscofulvin; Grisefuline; Griseo; Griseofulvina; Griseofulvine; Griseofulvinum; Griseomix; Griseostatin; Grisetin; Grisofulvin; Grisovin; Grizeofulvin; Grysio; Guservin; Lamoryl; Likuden; Likunden; Murfulvin; Poncyl; Spirofulvin; Sporostatin; Xuanjing; Curling fact or; Curling factor; Fulvican grisactin; Fulvicin U F; Grifulvin V; Gris PEG; Grisactin Ultra; Grise ostatin; Griseofulvin forte; Grisovin FP; Interacts with polymerized microtubules and associated proteins; Sporostatin xan; Biogrisin-FP; FULVICIN P/G 165; FULVICIN P/G 330;Fulvicin Bolus (Veterinary); Fulvicin P/G; Fulvicin U/F; Fulvidex (Veterinary); GRISEOFULVIN, MICROCRYSTALLINE; GRISEOFULVIN, ULTRAMICROCRYSTALLINE; Gris-PEG; Griseofulvin and Alpha-IFN; Griseofulvin-forte; Griseofulvina [INN-Spanish]; Griseofulvine [INN-French]; Griseofulvinum [INN-Latin]; Grisovin (TN); NP-002466; Neo-Fulcin; ULTRAGRIS-165; ULTRAGRIS-330; USAF SC-2; Fulvicin-P/G; Fulvicin-U-F; Fulvicin-U/F; Fulvicin-U/F (Veterinary); Griseofulvin [USAN:INN:BAN:JAN]; (+)-Griseofulvin; 7-Chloro-4,6,2'-trimethoxy-6'-methylgris-2'-en-3,4'-dione
    Click to Show/Hide
  Disease Class 1F28: Dermatophytosis
  Therapeutic Class Antifungal Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C17H17ClO6
  InChI 1S/C17H17ClO6/c1-8-5-9(19)6-12(23-4)17(8)16(20)13-10(21-2)7-11(22-3)14(18)15(13)24-17/h6-8H,5H2,1-4H3/t8-,17+/m1/s1
  InChIKey DDUHZTYCFQRHIY-RBHXEPJQSA-N
  Canonical SMILES CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC
  External Link
Pubchem ID 441140
CAS Number 126-07-8
CHEBI ID 27779
TTD ID D0C1SF
INTEDE ID DR0791

Drug-Drug Interaction Network
  Sunburst Graph
AM001  Affected gastrointestinal absorption
AM004  Affected intra/extra-hepatic metabolism
AM005  Affected excretion pathways
AM006  Pharmacodynamic additive effects
BM001  Altered gastrointestinal dynamics
BM009  Altered absorption (Unspecific)
BM022  CYP450 enzyme induction
BM032  Decreased renal excretion (Unspecific)
BM055  Increased risk of hepatotoxicity
BM075  Increased risk of photosensitivity reactions
  Relation Graph
 Full list of drugs interacting with Griseofulvin
      Affected gastrointestinal absorption
   Altered gastrointestinal dynamics Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0936
 
Liraglutide
 
C172H265N43O51
 
16134956 
Minor    Inter Info   
[356]
   Altered absorption (Unspecific) Drug Num:  10
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0224
 
Butabarbital
 
C10H16N2O3
 
2479 
Moderate    Inter Info   
[20], [21], [22]
D0225
 
Butalbital
 
C11H16N2O3
 
2481 
Moderate    Inter Info   
[20], [21], [22]
D0071
 
Amobarbital
 
C11H18N2O3
 
2164 
Moderate    Inter Info   
[20], [21], [22]
D1024
 
Methohexital
 
C14H18N2O3
 
9034 
Moderate    Inter Info   
[20], [21], [22]
D1040
 
Methylphenobarbital
 
C13H14N2O3
 
8271 
Moderate    Inter Info   
[20], [21], [22]
D1265
 
Phenobarbital
 
C12H12N2O3
 
4763 
Moderate    Inter Info   
[20], [21], [22]
D1340
 
Primidone
 
C12H14N2O2
 
4909 
Moderate    Inter Info   
[20], [21], [22]
D1453
 
Secobarbital
 
C12H18N2O3
 
5193 
Moderate    Inter Info   
[20], [21], [22]
D1248
 
Pentobarbital
 
C11H18N2O3
 
4737 
Moderate    Inter Info   
[20], [21], [22]
D0017
 
Acetylsalicylic acid
 
C9H8O4
 
2244 
Minor    Inter Info   
[350], [351], [352]
      Affected intra/extra-hepatic metabolism
   CYP450 enzyme induction Drug Num:  205
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0626
 
Etonogestrel
 
C22H28O2
 
6917715 
Major    Inter Info   
[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0485
 
Dienogest
 
C20H25NO2
 
68861 
Major    Inter Info   
[3], [6], [10]
D0536
 
Drospirenone
 
C24H30O3
 
68873 
Major    Inter Info   
[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0619
 
Ethinylestradiol
 
C20H24O2
 
5991 
Major    Inter Info   
[3], [6], [10]
D0909
 
Levacetylmethadol
 
C23H31NO2
 
15130 
Major    Inter Info   
[16], [17]
D0959
 
Lumateperone
 
C24H28FN3O
 
21302490 
Major    Inter Info   
[18]
D0990
 
Medroxyprogesterone acetate
 
C24H34O4
 
6279 
Major    Inter Info   
[3], [6], [10]
D1154
 
Norethisterone
 
C20H26O2
 
6230 
Major    Inter Info   
[3], [6], [10]
D1156
 
Norgestimate
 
C23H31NO3
 
6540478 
Major    Inter Info   
[3], [6], [10]
D1157
 
Norgestrel
 
C21H28O2
 
13109 
Major    Inter Info   
[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0922
 
Levonorgestrel
 
C21H28O2
 
13109 
Major    Inter Info   
[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1383
 
Ranolazine
 
C24H33N3O4
 
56959 
Major    Inter Info   
[19]
D0387
 
Conjugated estrogens
 
C18H21NaO5S
 
45357473 
Moderate    Inter Info   
[23], [24], [25], [26], [27], [28], [29], [30], [31], [3], [32], [33], [34], [35], [4], [36], [37], [5], [38], [39], [40], [41], [42], [43], [44], [45], [46], [8], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [10], [58], [11], [12], [13], [59], [60], [61]
D0481
 
Dicoumarol
 
C19H12O6
 
54676038 
Moderate    Inter Info   
[64], [65], [66]
D0494
 
Dihydroergotamine
 
C33H37N5O5
 
10531 
Moderate    Inter Info   
[67], [68], [69]
D0497
 
Diltiazem
 
C22H26N2O4S
 
39186 
Moderate    Inter Info   
[31], [70], [71], [72], [55]
D0713
 
Gefitinib
 
C22H24ClFN4O3
 
123631 
Moderate    Inter Info   
[73], [74]
D0006
 
Abemaciclib
 
C27H32F2N8
 
46220502 
Moderate    Inter Info   
[75]
D0008
 
Acalabrutinib
 
C26H23N7O2
 
71226662 
Moderate    Inter Info   
[76]
D0035
 
Alfentanil
 
C21H32N6O3
 
51263 
Moderate    Inter Info   
[77], [78], [79], [80]
D0044
 
Alpelisib
 
C19H22F3N5O2S
 
56649450 
Moderate    Inter Info   
[81]
D0080
 
Amprenavir
 
C25H35N3O6S
 
65016 
Moderate    Inter Info   
[83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99]
D0087
 
Anisindione
 
C16H12O3
 
2197 
Moderate    Inter Info   
[64], [100], [101], [65], [66], [102]
D0096
 
Apixaban
 
C25H25N5O4
 
10182969 
Moderate    Inter Info   
[103]
D0099
 
Apremilast
 
C22H24N2O7S
 
11561674 
Moderate    Inter Info   
[104]
D0100
 
Aprepitant
 
C23H21F7N4O3
 
135413536 
Moderate    Inter Info   
[105], [106]
D0105
 
Aripiprazole
 
C23H27Cl2N3O2
 
60795 
Moderate    Inter Info   
[107]
D0106
 
Armodafinil
 
C15H15NO2S
 
9690109 
Moderate    Inter Info   
[108], [109]
D0108
 
Artemether
 
C16H26O5
 
68911 
Moderate    Inter Info   
[67], [68], [110]
D0116
 
Atazanavir
 
C38H52N6O7
 
148192 
Moderate    Inter Info   
[83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99]
D0120
 
Atorvastatin
 
C33H35FN2O5
 
60823 
Moderate    Inter Info   
[111], [112], [113], [114], [115]
D0128
 
Avanafil
 
C23H26ClN7O3
 
9869929 
Moderate    Inter Info   
[116]
D0129
 
Avapritinib
 
C26H27FN10
 
118023034 
Moderate    Inter Info   
[68], [117]
D0133
 
Axitinib
 
C22H18N4OS
 
6450551 
Moderate    Inter Info   
[118], [119]
D0149
 
Bedaquiline
 
C32H31BrN2O2
 
5388906 
Moderate    Inter Info   
[120]
D0161
 
Benzhydrocodone
 
C25H25NO4
 
49836084 
Moderate    Inter Info   
[121], [122], [123]
D0181
 
Bictegravir
 
C21H18F3N3O5
 
90311989 
Moderate    Inter Info   
[68], [124], [125]
D0192
 
Boceprevir
 
C27H45N5O5
 
10324367 
Moderate    Inter Info   
[126], [127]
D0195
 
Bosutinib
 
C26H29Cl2N5O3
 
5328940 
Moderate    Inter Info   
[128]
D0204
 
Brigatinib
 
C29H39ClN7O2P
 
68165256 
Moderate    Inter Info   
[67], [68], [129]
D0219
 
Buprenorphine
 
C29H41NO4
 
644073 
Moderate    Inter Info   
[130]
D0222
 
Buspirone
 
C21H31N5O2
 
2477 
Moderate    Inter Info   
[131], [132], [133]
D0226
 
Butorphanol
 
C21H29NO2
 
5361092 
Moderate    Inter Info   
[134], [121], [135], [67], [68], [136], [137], [138], [122], [139], [140], [141], [142], [143], [144], [145], [146], [147], [123]
D0227
 
Cabazitaxel
 
C45H57NO14
 
9854073 
Moderate    Inter Info   
[148]
D0230
 
Cabozantinib
 
C28H24FN3O5
 
25102847 
Moderate    Inter Info   
[149], [150]
D0251
 
Capmatinib
 
C23H17FN6O
 
25145656 
Moderate    Inter Info   
[151]
D0255
 
Carbamazepine
 
C15H12N2O
 
2554 
Moderate    Inter Info   
[152], [153], [154], [155], [156], [157], [158], [159]
D0268
 
Caspofungin
 
C52H88N10O15
 
2826718 
Moderate    Inter Info   
[160]
D0376
 
Cobimetinib
 
C21H21F3IN3O2
 
16222096 
Moderate    Inter Info   
[161]
D0389
 
Copanlisib
 
C23H28N8O4
 
135565596 
Moderate    Inter Info   
[162]
D0393
 
Crizotinib
 
C21H22Cl2FN5O
 
11626560 
Moderate    Inter Info   
[163], [68], [164]
D0424
 
Darifenacin
 
C28H30N2O2
 
444031 
Moderate    Inter Info   
[165]
D0425
 
Darolutamide
 
C19H19ClN6O2
 
67171867 
Moderate    Inter Info   
[166]
D0426
 
Darunavir
 
C27H37N3O7S
 
213039 
Moderate    Inter Info   
[83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99]
D0439
 
Delavirdine
 
C22H28N6O3S
 
5625 
Moderate    Inter Info   
[167], [168]
D0511
 
Docetaxel
 
C43H53NO14
 
148124 
Moderate    Inter Info   
[169], [170], [171], [172], [173]
D0516
 
Donepezil
 
C24H29NO3
 
3152 
Moderate    Inter Info   
[174]
D0518
 
Doravirine
 
C17H11ClF3N5O3
 
58460047 
Moderate    Inter Info   
[175], [176]
D0528
 
Doxorubicin
 
C27H29NO11
 
31703 
Moderate    Inter Info   
[68], [177], [178], [179]
D0529
 
Doxorubicin (liposomal)
 
C27H29NO11
 
31703 
Moderate    Inter Info   
[177], [178], [179]
D0534
 
Dronedarone
 
C31H44N2O5S
 
208898 
Moderate    Inter Info   
[180]
D0543
 
Duvelisib
 
C22H17ClN6O
 
50905713 
Moderate    Inter Info   
[181]
D0554
 
Efavirenz
 
C14H9ClF3NO2
 
64139 
Moderate    Inter Info   
[182], [72]
D0555
 
Elagolix
 
C32H30F5N3O5
 
11250647 
Moderate    Inter Info   
[183]
D0556
 
Elbasvir
 
C49H55N9O7
 
71661251 
Moderate    Inter Info   
[184]
D0559
 
Eliglustat
 
C23H36N2O4
 
23652731 
Moderate    Inter Info   
[185]
D0569
 
Encorafenib
 
C22H27ClFN7O4S
 
50922675 
Moderate    Inter Info   
[186]
D0577
 
Entrectinib
 
C31H34F2N6O2
 
25141092 
Moderate    Inter Info   
[187]
D0578
 
Enzalutamide
 
C21H16F4N4O2S
 
15951529 
Moderate    Inter Info   
[188]
D0592
 
Ergometrine
 
C19H23N3O2
 
443884 
Moderate    Inter Info   
[67], [68], [69]
D0593
 
Ergotamine
 
C33H35N5O5
 
8223 
Moderate    Inter Info   
[67], [68], [69]
D0595
 
Erlotinib
 
C22H23N3O4
 
176870 
Moderate    Inter Info   
[73], [189]
D0605
 
Esterified estrogens
 
NA
 
NA
Moderate    Inter Info   
[23], [24], [25], [26], [27], [28], [29], [30], [31], [3], [32], [33], [34], [35], [4], [36], [37], [5], [38], [39], [40], [41], [42], [43], [44], [45], [46], [8], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [10], [58], [11], [12], [13], [59], [60], [61]
D0606
 
Estradiol
 
C18H24O2
 
5757 
Moderate    Inter Info   
[23], [24], [25], [26], [27], [28], [29], [30], [31], [3], [32], [33], [34], [35], [4], [36], [37], [5], [38], [39], [40], [41], [42], [43], [44], [45], [46], [8], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [10], [58], [11], [12], [13], [59], [60], [61]
D0607
 
Estradiol (topical)
 
C18H24O2
 
5757 
Moderate    Inter Info   
[27], [4], [10]
D0609
 
Estrone
 
C18H22O2
 
5870 
Moderate    Inter Info   
[23], [24], [25], [26], [27], [28], [29], [30], [31], [3], [32], [33], [34], [35], [4], [36], [37], [5], [38], [39], [40], [41], [42], [43], [44], [45], [46], [8], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [10], [58], [11], [12], [13], [59], [60], [61]
D0610
 
Estrone sulfate
 
C18H22O5S
 
3001028 
Moderate    Inter Info   
[27], [4], [10]
D0612
 
Eszopiclone
 
C17H17ClN6O3
 
969472 
Moderate    Inter Info   
[190]
D0628
 
Etravirine
 
C20H15BrN6O
 
193962 
Moderate    Inter Info   
[191]
D0629
 
Everolimus
 
C53H83NO14
 
6442177 
Moderate    Inter Info   
[67], [68], [192]
D0630
 
Exemestane
 
C20H24O2
 
60198 
Moderate    Inter Info   
[193]
D0646
 
Fentanyl
 
C22H28N2O
 
3345 
Moderate    Inter Info   
[134], [121], [135], [67], [68], [136], [137], [138], [122], [139], [140], [141], [142], [143], [144], [145], [146], [147], [123]
D0655
 
Fesoterodine
 
C26H37NO3
 
6918558 
Moderate    Inter Info   
[194]
D0665
 
Flibanserin
 
C20H21F3N4O
 
6918248 
Moderate    Inter Info   
[195]
D0692
 
Fosamprenavir
 
C25H36N3O9PS
 
131536 
Moderate    Inter Info   
[83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99]
D0693
 
Fosaprepitant
 
C23H22F7N4O6P
 
135413538 
Moderate    Inter Info   
[105], [106]
D0699
 
Fostamatinib
 
C23H26FN6O9P
 
11671467 
Moderate    Inter Info   
[196]
D0720
 
Gilteritinib
 
C29H44N8O3
 
49803313 
Moderate    Inter Info   
[197]
D0726
 
Glecaprevir
 
C38H46F4N6O9S
 
66828839 
Moderate    Inter Info   
[198]
D0745
 
Guanfacine
 
C9H9Cl2N3O
 
3519 
Moderate    Inter Info   
[68], [199], [200]
D0772
 
Hydrocodone
 
C18H21NO3
 
5284569 
Moderate    Inter Info   
[134], [121], [135], [67], [68], [136], [137], [138], [122], [139], [140], [141], [142], [143], [144], [145], [146], [147], [123]
D0785
 
Ibrutinib
 
C25H24N6O2
 
24821094 
Moderate    Inter Info   
[201]
D0789
 
Idelalisib
 
C22H18FN7O
 
11625818 
Moderate    Inter Info   
[202]
D0793
 
Imatinib
 
C29H31N7O
 
5291 
Moderate    Inter Info   
[203], [86], [67], [68], [204], [205]
D0845
 
Irinotecan
 
C33H38N4O6
 
60838 
Moderate    Inter Info   
[206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220]
D0846
 
Irinotecan (liposomal)
 
C33H38N4O6
 
60838 
Moderate    Inter Info   
[207], [208], [213]
D0852
 
Isavuconazonium
 
C35H35F2N8O5S+
 
6918606 
Moderate    Inter Info   
[221]
D0868
 
Ivabradine
 
C27H36N2O5
 
132999 
Moderate    Inter Info   
[68], [222]
D0869
 
Ivacaftor
 
C24H28N2O3
 
16220172 
Moderate    Inter Info   
[223], [224], [225], [226]
D0873
 
Ixabepilone
 
C27H42N2O5S
 
6445540 
Moderate    Inter Info   
[227]
D0874
 
Ixazomib
 
C14H19BCl2N2O4
 
25183872 
Moderate    Inter Info   
[228]
D0894
 
Lapatinib
 
C29H26ClFN4O4S
 
208908 
Moderate    Inter Info   
[67], [68], [229]
D0896
 
Larotrectinib
 
C21H22F2N6O2
 
46188928 
Moderate    Inter Info   
[67], [68], [230]
D0899
 
Lefamulin
 
C28H45NO5S
 
25185057 
Moderate    Inter Info   
[231]
D0901
 
Lemborexant
 
C22H20F2N4O2
 
56944144 
Moderate    Inter Info   
[67], [232]
D0930
 
Linagliptin
 
C25H28N8O2
 
10096344 
Moderate    Inter Info   
[233]
D0946
 
Lonafarnib
 
C27H31Br2ClN4O2
 
148195 
Moderate    Inter Info   
[234]
D0961
 
Lurasidone
 
C28H36N4O2S
 
213046 
Moderate    Inter Info   
[67], [68], [235]
D0962
 
Lurbinectedin
 
C41H44N4O10S
 
57327016 
Moderate    Inter Info   
[236]
D0965
 
Macimorelin
 
C26H30N6O3
 
9804938 
Moderate    Inter Info   
[237]
D0966
 
Macitentan
 
C19H20Br2N6O4S
 
16004692 
Moderate    Inter Info   
[238], [239]
D0980
 
Maraviroc
 
C29H41F2N5O
 
3002977 
Moderate    Inter Info   
[67], [240]
D1062
 
Midostaurin
 
C35H30N4O4
 
9829523 
Moderate    Inter Info   
[244], [245]
D1063
 
Mifepristone
 
C29H35NO2
 
55245 
Moderate    Inter Info   
[246], [247]
D1081
 
Modafinil
 
C15H15NO2S
 
4236 
Moderate    Inter Info   
[108], [109]
D1087
 
Montelukast
 
C35H36ClNO3S
 
5281040 
Moderate    Inter Info   
[248]
D1104
 
Naloxegol
 
C34H53NO11
 
56959087 
Moderate    Inter Info   
[249]
D1136
 
Nilotinib
 
C28H22F3N7O
 
644241 
Moderate    Inter Info   
[250]
D1167
 
Olaparib
 
C24H23FN4O3
 
23725625 
Moderate    Inter Info   
[67], [68], [251]
D1169
 
Oliceridine
 
C22H30N2O2S
 
66553195 
Moderate    Inter Info   
[134], [121], [135], [67], [68], [136], [137], [138], [122], [139], [140], [141], [142], [143], [144], [145], [146], [147], [123]
D1190
 
Osimertinib
 
C28H33N7O2
 
71496458 
Moderate    Inter Info   
[252]
D1203
 
Oxycodone
 
C18H21NO4
 
5284603 
Moderate    Inter Info   
[134], [121], [135], [67], [68], [136], [137], [138], [122], [139], [140], [141], [142], [143], [144], [145], [146], [147], [123]
D1212
 
Paclitaxel
 
C47H51NO14
 
36314 
Moderate    Inter Info   
[253], [254], [255], [256]
D1213
 
Paclitaxel (protein-bound)
 
C47H51NO14
 
36314 
Moderate    Inter Info   
[253], [254], [255]
D1214
 
Palbociclib
 
C24H29N7O2
 
5330286 
Moderate    Inter Info   
[67], [68], [257]
D1221
 
Panobinostat
 
C21H23N3O2
 
6918837 
Moderate    Inter Info   
[258]
D1232
 
Pazopanib
 
C21H23N7O2S
 
10113978 
Moderate    Inter Info   
[259]
D1242
 
Pemigatinib
 
C24H27F2N5O4
 
86705695 
Moderate    Inter Info   
[68], [260]
D1253
 
Perampanel
 
C23H15N3O
 
9924495 
Moderate    Inter Info   
[68], [261]
D1290
 
Pimavanserin
 
C25H34FN3O2
 
10071196 
Moderate    Inter Info   
[262]
D1313
 
Ponatinib
 
C29H27F3N6O
 
24826799 
Moderate    Inter Info   
[67], [68], [263]
D1330
 
Praziquantel
 
C19H24N2O2
 
4891 
Moderate    Inter Info   
[266], [67], [267], [268]
D1368
 
Quetiapine
 
C21H25N3O2S
 
5002 
Moderate    Inter Info   
[67], [269], [270], [271], [272]
D1370
 
Quinestrol
 
C25H32O2
 
9046 
Moderate    Inter Info   
[23], [24], [25], [26], [27], [28], [29], [30], [31], [3], [32], [33], [34], [35], [4], [36], [37], [5], [38], [39], [40], [41], [42], [43], [44], [45], [46], [8], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [10], [58], [11], [12], [13], [59], [60], [61]
D1372
 
Quinine
 
C20H24N2O2
 
3034034 
Moderate    Inter Info   
[273], [274], [275], [276], [277], [278]
D1378
 
Ramelteon
 
C16H21NO2
 
208902 
Moderate    Inter Info   
[279]
D1392
 
Repaglinide
 
C27H36N2O4
 
65981 
Moderate    Inter Info   
[280], [281], [282]
D1398
 
Ribociclib
 
C23H30N8O
 
44631912 
Moderate    Inter Info   
[67], [68], [283]
D1404
 
Rilpivirine
 
C22H18N6
 
6451164 
Moderate    Inter Info   
[67], [163], [68], [284]
D1409
 
Ripretinib
 
C24H21BrFN5O2
 
71584930 
Moderate    Inter Info   
[67], [285]
D1415
 
Ritonavir
 
C37H48N6O5S2
 
392622 
Moderate    Inter Info   
[83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99]
D1417
 
Rivaroxaban
 
C19H18ClN3O5S
 
9875401 
Moderate    Inter Info   
[286]
D1423
 
Rolapitant
 
C25H26F6N2O2
 
10311306 
Moderate    Inter Info   
[287]
D1434
 
Ruxolitinib
 
C17H18N6
 
25126798 
Moderate    Inter Info   
[288]
D1444
 
Saquinavir
 
C38H50N6O5
 
441243 
Moderate    Inter Info   
[83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99]
D1449
 
Saxagliptin
 
C18H25N3O2
 
11243969 
Moderate    Inter Info   
[289]
D1459
 
Selpercatinib
 
C29H31N7O3
 
134436906 
Moderate    Inter Info   
[68], [290]
D1460
 
Selumetinib
 
C17H15BrClFN4O3
 
10127622 
Moderate    Inter Info   
[291]
D1466
 
Silodosin
 
C25H32F3N3O4
 
5312125 
Moderate    Inter Info   
[67], [68], [292]
D1476
 
Sirolimus
 
C51H79NO13
 
5284616 
Moderate    Inter Info   
[67], [68], [293], [294]
D1491
 
Solifenacin
 
C23H26N2O2
 
154059 
Moderate    Inter Info   
[295]
D1496
 
Sonidegib
 
C26H26F3N3O3
 
24775005 
Moderate    Inter Info   
[296]
D1505
 
Stiripentol
 
C14H18O3
 
5311454 
Moderate    Inter Info   
[68], [204], [297]
D1522
 
Sunitinib
 
C22H27FN4O2
 
5329102 
Moderate    Inter Info   
[67], [68], [298]
D1524
 
Suvorexant
 
C23H23ClN6O2
 
24965990 
Moderate    Inter Info   
[299]
D1526
 
Tacrolimus
 
C44H69NO12
 
445643 
Moderate    Inter Info   
[67], [68], [293], [294]
D1527
 
Tadalafil
 
C22H19N3O4
 
110635 
Moderate    Inter Info   
[68], [300], [301]
D1533
 
Tamoxifen
 
C26H29NO
 
2733526 
Moderate    Inter Info   
[302], [303], [304], [305]
D1536
 
Tasimelteon
 
C15H19NO2
 
10220503 
Moderate    Inter Info   
[306]
D1538
 
Tazemetostat
 
C34H44N4O4
 
66558664 
Moderate    Inter Info   
[307]
D1544
 
Telithromycin
 
C43H65N5O10
 
3002190 
Moderate    Inter Info   
[308], [309]
D1549
 
Temsirolimus
 
C56H87NO16
 
6918289 
Moderate    Inter Info   
[67], [68], [310]
D1579
 
Ticagrelor
 
C23H28F2N6O4S
 
9871419 
Moderate    Inter Info   
[86], [68], [311], [312], [313]
D1592
 
Tipranavir
 
C31H33F3N2O5S
 
54682461 
Moderate    Inter Info   
[83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99]
D1600
 
Tofacitinib
 
C16H20N6O
 
9926791 
Moderate    Inter Info   
[67], [314]
D1608
 
Tolvaptan
 
C26H25ClN2O3
 
216237 
Moderate    Inter Info   
[68], [315]
D1612
 
Toremifene
 
C26H28ClNO
 
3005573 
Moderate    Inter Info   
[316], [67], [68], [303], [317]
D1615
 
Trabectedin
 
C39H43N3O11S
 
108150 
Moderate    Inter Info   
[68], [318], [319]
D1660
 
Tucatinib
 
C26H24N8O2
 
51039094 
Moderate    Inter Info   
[320]
D1663
 
Ubrogepant
 
C29H26F3N5O3
 
68748835 
Moderate    Inter Info   
[321]
D1664
 
Ulipristal
 
C28H35NO3
 
13559281 
Moderate    Inter Info   
[68], [322]
D1687
 
Vemurafenib
 
C23H18ClF2N3O3S
 
42611257 
Moderate    Inter Info   
[323]
D1688
 
Venetoclax
 
C45H50ClN7O7S
 
49846579 
Moderate    Inter Info   
[324]
D1697
 
Vinblastine
 
C46H58N4O9
 
13342 
Moderate    Inter Info   
[325]
D1698
 
Vincristine
 
C46H56N4O10
 
5978 
Moderate    Inter Info   
[325]
D1706
 
Voriconazole
 
C16H14F3N5O
 
71616 
Moderate    Inter Info   
[326]
D1708
 
Vortioxetine
 
C18H22N2S
 
9966051 
Moderate    Inter Info   
[327]
D1711
 
Warfarin
 
C19H16O4
 
54678486 
Moderate    Inter Info   
[64], [100], [101], [65], [66], [102]
D1718
 
Zanubrutinib
 
C27H29N5O3
 
135565884 
Moderate    Inter Info   
[328]
D1729
 
Zolpidem
 
C19H21N3O
 
5732 
Moderate    Inter Info   
[68], [329], [330], [331]
D1730
 
Zonisamide
 
C8H8N2O3S
 
5734 
Moderate    Inter Info   
[332], [333]
D0799
 
Indinavir
 
C36H47N5O4
 
5362440 
Moderate    Inter Info   
[83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99]
D0992
 
Mefloquine
 
C17H16F6N2O
 
4046 
Moderate    Inter Info   
[334]
D0993
 
Megestrol acetate
 
C24H32O4
 
11683 
Moderate    Inter Info   
[27], [4], [10]
D1017
 
Methadone
 
C21H27NO
 
4095 
Moderate    Inter Info   
[134], [121], [135], [67], [68], [136], [137], [138], [122], [139], [140], [141], [142], [143], [144], [145], [146], [147], [123]
D1037
 
Methylergometrine
 
C20H25N3O2
 
8226 
Moderate    Inter Info   
[67], [68], [69]
D1043
 
Methysergide
 
C21H27N3O2
 
9681 
Moderate    Inter Info   
[67], [68], [69]
D1075
 
Mirtazapine
 
C17H19N3
 
4205 
Moderate    Inter Info   
[335], [336], [337], [338]
D1119
 
Nelfinavir
 
C32H45N3O4S
 
64143 
Moderate    Inter Info   
[83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99]
D1143
 
Nitisinone
 
C14H10F3NO5
 
115355 
Moderate    Inter Info   
[86], [67], [68]
D1348
 
Progesterone
 
C21H30O2
 
5994 
Moderate    Inter Info   
[23], [24], [25], [26], [27], [28], [29], [30], [31], [3], [32], [33], [34], [35], [4], [36], [37], [5], [38], [39], [40], [41], [42], [43], [44], [45], [46], [8], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [10], [58], [11], [12], [13], [59], [60], [61]
D1349
 
Progesterone (topical)
 
C21H30O2
 
5994 
Moderate    Inter Info   
[27], [4], [10]
D1465
 
Sildenafil
 
C22H30N6O4S
 
135398744 
Moderate    Inter Info   
[339], [340], [341], [342]
D1497
 
Sorafenib
 
C21H16ClF3N4O3
 
216239 
Moderate    Inter Info   
[343]
D1700
 
Vinorelbine
 
C45H54N4O8
 
5311497 
Moderate    Inter Info   
[325]
D0178
 
Bexarotene
 
C24H28O2
 
82146 
Minor    Inter Info   
[305]
D0193
 
Bortezomib
 
C19H25BN4O4
 
387447 
Minor    Inter Info   
[68], [344], [345], [346], [347]
D0308
 
Cevimeline
 
C10H17NOS
 
83898 
Minor    Inter Info   
[348]
D0420
 
Dapsone (topical)
 
C12H12N2O2S
 
2955 
Minor    Inter Info   
[349], [223], [226]
D0515
 
Dolutegravir
 
C20H19F2N3O5
 
54726191 
Minor    Inter Info   
[353]
D0700
 
Fostemsavir
 
C25H26N7O8P
 
11319217 
Minor    Inter Info   
[354]
D0916
 
Levobupivacaine
 
C18H28N2O
 
92253 
Minor    Inter Info   
[355]
D1074
 
Mirabegron
 
C21H24N4O2S
 
9865528 
Minor    Inter Info   
[357]
D0927
 
Lidocaine
 
C14H22N2O
 
3676 
Minor    Inter Info   
[358], [359], [360], [361]
D1726
 
Ziprasidone
 
C21H21ClN4OS
 
60854 
Minor    Inter Info   
[362], [363]
      Affected excretion pathways
   Decreased renal excretion (Unspecific) Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0402
 
Cyclosporine
 
C62H111N11O12
 
5284373 
Moderate    Inter Info   
[9], [62], [63]
      Pharmacodynamic additive effects
   Increased risk of hepatotoxicity Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0880
 
Ketoconazole
 
C26H28Cl2N4O4
 
456201 
Moderate    Inter Info   
[67]
   Increased risk of photosensitivity reactions Drug Num:  5
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0062
 
Aminolevulinic acid
 
C5H9NO3
 
137 
Major    Inter Info   
[14], [15]
D0063
 
Aminolevulinic acid (topical)
 
C5H9NO3
 
137 
Moderate    Inter Info   
[67], [68], [82]
D1028
 
Methoxsalen
 
C12H8O4
 
4114 
Moderate    Inter Info   
[67], [241], [14], [242], [243]
D1033
 
Methyl aminolevulinate (topical)
 
C6H11NO3
 
157922 
Moderate    Inter Info   
[67], [68], [82]
D1314
 
Porfimer sodium
 
C68H74N8O11
 
135577896 
Moderate    Inter Info   
[264], [68], [265]
References
1 Back DJ, Grimmer SF, Orme ML, Proudlove D, Mann RD, Breckenridge AM "Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics." Br J Clin Pharmacol 25 (1988): 527-32. [PMID: 3408633]
2 Bollen M "Use of antibiotics when taking the oral contraceptive pill." Aust Fam Physician 24 (1995): 928-9. [PMID: 7794163]
3 Cote J "Interaction of griseofulvin and oral contraceptives." J Am Acad Dermatol 22 (1990): 124-5. [PMID: 2298948]
4 Dickinson BD, Altman RD, Nielsen NH, Sterling ML "Drug interactions between oral contraceptives and antibiotics." Obstet Gynecol 98(5 Pt 1) (2001): 853-60. [PMID: 11704183]
5 Faculty of Sexual & Reproductive Healthcare "FSRH Clinical Guidance: Drug Interactions with Hormonal Contraception.".
6 FFPRHC Guidance (April 2005). Drug interactions with hormonal contraception. J Fam Plann Reprod Health Care 31 (2005): 139-51. [PMID: 15921558]
7 Helms SE, Bredle DL, Zajic J, Jarjoura D, Brodell RT, Krishnarao I "Oral contraceptive failure rates and oral antibiotics." J Am Acad Dermatol 36 (1997): 705-10. [PMID: 9146531]
8 McDaniel PA, Caldroney RD "Oral contraceptives and griseofulvin interaction." Drug Intell Clin Pharm 20 (1986): 384. [PMID: 3709350]
9 Product Information. Grifulvin V (griseofulvan). Ortho Pharmaceuticals, Raritan, NJ. (1992):.
10 van Dijke CP, Weber JC "Interaction between oral contraceptives and griseofulvin." Br Med J (Clin Res Ed) 288 (1984): 1125-6. [PMID: 2143563]
11 Weaver K, Glasier A "Interaction between broad-spectrum antibiotics and the combined oral contraceptive pill: a literature review." Contraception 59 (1999): 71-8. [PMID: 10361620]
12 Weber JC "Interaction between oral contraceptives and griseofulvin." Br Med J 288 (1984): 1125-6. [PMID: 6424759]
13 Weisberg E "Interactions between oral contraceptives and antifungals antibacterials - Is contraceptive failure the result?." Clin Pharmacokinet 36 (1999): 309-13. [PMID: 10384856]
14 Product Information. Nulibry (fosdenopterin). Origin Biosciences Inc, Boston, MA.
15 Product Information. Gleolan (aminolevulinic acid). NX Development Corp, Lexington, KY.
16 Patel S, Robinson R, Burk M "Hypertensive crisis associated with St. John's Wort." Am J Med 112 (2002): 507-8. [PMID: 11959071]
17 Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
18 Product Information. Caplyta (lumateperone). Intra-Cellular Therapies, Inc., New York, NY.
19 Product Information. Ranexa (ranolazine). Calmoseptine Inc, Huntington Beach, CA.
20 Busfield D, Child KJ, Atkinson RM, Tomich EG "An effect of phenobarbitone on blood-levels of griseofulvin in man." Lancet 2 (1963): 1042-3. [PMID: 14062729]
21 Kraml M, Marton AV, Dvornik D, Chappel C, Garbaczewska L "Effect of primidone (Mysoline) on tissular levels of griseofulvin in the rat." Proc Soc Exp Biol Med 120 (1965): 678-9. [PMID: 5858690]
22 Riegelman S, Rowland M, Epstein WL "Griseofulvin-phenobarbital interaction in man." JAMA 213 (1970): 426-31. [PMID: 5468016]
23 Baciewicz AM "Oral contraceptive drug interactions." Ther Drug Monit 7 (1985): 26-35. [PMID: 2859674]
24 Baciewicz AM, Self TH "Rifampin drug interactions." Arch Intern Med 144 (1984): 1667-71. [PMID: 6380442]
25 Back DJ, Bates M, Bowden A, et al "The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy." Contraception 22 (1980): 495-503. [PMID: 7471739]
26 Back DJ, Breckenridge AM, Crawford FE, et al. "The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women." Contraception 21 (1980): 135-43. [PMID: 7189454]
27 Back DJ, Breckenridge AM, Crawford FE, MacIver M, Orne ML, Rowe PH "Interindividual variation and drug interactions with hormonal steroid contraceptives." Drugs 21 (1981): 46-61. [PMID: 7009137]
28 Back DJ, Orme ML "Pharmacokinetic drug interactions with oral contraceptives." Clin Pharmacokinet 18 (1990): 472-84. [PMID: 2191822]
29 Barditch-Crovo P, Trapnell CB, Ette E, et al "The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive." Clin Pharmacol Ther 65 (1999): 428-38. [PMID: 10223781]
30 Bolt HM, Bolt M, Kappus H "Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man." Acta Endocrinol (Copenh) 85 (1977): 189-97. [PMID: 577076]
31 Borcherding SM, Baciewicz AM, Self TH "Update on rifampin drug interactions." Arch Intern Med 152 (1992): 711-6. [PMID: 1558427]
32 Coulam CB, Annegers JF "Do anticonvulsants reduce the efficacy of oral contraceptives?" Epilepsia 20 (1979): 519-26. [PMID: 477641]
33 Crawford P, Chadwick DJ, Martin C, et al "The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids." Br J Clin Pharmacol 30 (1990): 892-6. [PMID: 2126946]
34 Curran MA "Drug interactions with the pill." Med J Aust 144 (1986): 670-1. [PMID: 3086681]
35 D'Arcy PF "Drug interactions with oral contraceptives." Drug Intell Clin Pharm 20 (1986): 353-62. [PMID: 3519141]
36 D'Arcy PF. Drug interactions with oral contraceptives. Drug Intell Clin Pharm. 1986;20(5):353-362. [PMID: 3519141]
37 Durr D, Stieger B, KullakUblick GA, Rentsch KM, Steinert HC, Meier PJ, Fattinger K "St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4." Clin Pharmacol Ther 68 (2000): 598-604. [PMID: 11180019]
38 Furlan AJ, Rothner AD "Anti-epileptic drugs and failure of oral contraceptives." Lancet 1 (1974): 1113. [PMID: 4135275]
39 Gorski JC, Hamman MA, Wang Z, Vasvada N, Huang S, Hall SD "The effect of St. John's wort on the efficacy of oral contraception." Clin Pharmacol Ther 71 (2002): P25. [PMID: 14663455]
40 Hall SD, Wang Z, Huang SM, et al. "The interaction between St John's wort and an oral contraceptive." Clin Pharmacol Ther 74 (2003): 525-35. [PMID: 14663455]
41 Halpenny O, Bye A, Cranny A, Feely J, Daly PA "Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate." Med Oncol Tumor Pharmacother 7 (1990): 241-7. [PMID: 2149401]
42 Janz D, Schmidt D "Letter: Anti-epileptic drugs and failure of oral contraceptives." Lancet 1 (1974): 1113. [PMID: 4135275]
43 Klosterskov Jensen P, Saano V, Haring P, Svenstrup B, Menge GP "Possible interaction between oxcarbazepine and an oral contraceptive." Epilepsia 33 (1992): 1149-52. [PMID: 1464278]
44 Laengner H, Detering K "Letter: Anti-epileptic drugs and failure of oral contraceptives." Lancet 2 (1974): 600. [PMID: 4140317]
45 LeBel M, Masson E, Guilbert E, Colborn D, Paquet F, Allard S, Vallee F, Narang PK "Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone." J Clin Pharmacol 38 (1998): 1042-50. [PMID: 9824786]
46 Mattson RH, Cramer JA, Darney PD, Naftolin F "Use of oral contraceptives by women with epilepsy." JAMA 256 (1986): 238-40. [PMID: 3723710]
47 Michalets EL "Update: clinically significant cytochrome P-450 drug interactions." Pharmacotherapy 18 (1998): 84-112. [PMID: 9469685]
48 Mumford JP "Letter: Drugs affecting oral contraceptives." Br Med J 2 (1974): 333-4. [PMID: 4827122]
49 Nocke-finck L "Effects of rifampicin on menstral cycle and on estrogen excretion in patients taking oral contraceptives." JAMA 226 (1973): 378. [PMID: 4580141]
50 Notelovitz M, Tjapkes J, Ware M "Interaction between estrogen and dilantin in a menopausal woman." N Engl J Med 304 (1981): 788-9. [PMID: 6258075]
51 Pfrunder A, Schiesser M, Gerber S, Haschke M, Bitzer J, Drewe J "Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial." Br J Clin Pharmacol 56 (2003): 683-90. [PMID: 14616430]
52 Product Information. Premarin (conjugated estrogens). Wyeth-Ayerst Laboratories, Philadelphia, PA.
53 Murphy PA. St. John's wort and oral contraceptives: reasons for concern?.?J Midwifery Womens Health. 2002;47(6):447-450. doi:10.1016/s1526-9523(02)00321-5. [PMID: 12484666]
54 Skolnick JL, Stoler BS, Katz DB, Anderson WH "Rifampin, oral contraceptives, and pregnancy." JAMA 236 (1976): 1382. [PMID: 989097]
55 Strayhorn VA, Baciewicz AM, Self TH "Update on rifampin drug interactions, III." Arch Intern Med 157 (1997): 2453-8. [PMID: 9385296]
56 Szoka PR, Edgren RA "Drug interactions with oral contraceptives: compilation and analysis of an adverse experience report database." Fertil Steril 49 (1988): s31-8. [PMID: 3282933]
57 Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception. Br J Clin Pharmacol 55 (2003): 112-113. [PMID: 12534648]
58 Venkatesan K "Pharmacokinetic drug interactions with rifampicin." Clin Pharmacokinet 22 (1992): 47-65. [PMID: 1559307]
59 Wilbur K, Ensom MHH "Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants." Clin Pharmacokinet 38 (2000): 355-65. [PMID: 10803456]
60 Zachariassen RD "Loss of oral contraceptive efficacy by concurrent antibiotic administration." Women Health 22 (1994): 17-26. [PMID: 7900401]
61 Lundgren S, Lonning PE, Aakvaag A, Kvinnsland S, Lnning PE "Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer." Cancer Chemother Pharmacol 27 (1990): 101-5. [PMID: 2249324]
62 Product Information. Fulvicin P/G (griseofulvin). Schering Laboratories, Kenilworth, NJ.
63 Abu-Romeh SH, Rashed A "Ciclosporin A and griseofulvin: another drug interaction." Nephron 58 (1991): 237
64 Koch-Weser J, Sellers EM "Drug interactions with coumarin anticoagulants (second of two parts)." N Engl J Med 285 (1971): 547-58. [PMID: 4397794]
65 Product Information. Sintrom (nicoumalone). Novartis Pharmaceuticals Canada Inc, Dorval, QC.
66 Thijssen HH, Flin ois JP, Beaune PH "Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes." Drug Metab Dispos 28 (2000): 1284-90. [PMID: 11038154]
67 Cerner Multum, Inc. "Australian Product Information.".
68 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
69 Product Information. Methergine (methylergonovine). Novartis Pharmaceuticals, East Hanover, NJ.
70 Lledo P, Abrams SM, Johnston A, Patel M, Pearson RM, Turner P. Influence of debrisoquine hydroxylation phenotype on the pharmacokinetics of mexiletine. Eur J Clin Pharmacol. 1993;44(1):63-67. [PMID: 8436157]
71 Product Information. Cardizem (diltiazem). Hoechst Marion-Roussel Inc, Kansas City, MO.
72 Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
73 Li J, Zhao M, He P, Hidalgo M, Baker SD "Differential metabolism of gefitinib and erlotinib by human cytochrome p450 enzymes." Clin Cancer Res 13 (2007): 3731-7. [PMID: 17575239]
74 Product Information. Iressa (gefitinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
75 Product Information. Verzenio (abemaciclib). Lilly, Eli and Company, Indianapolis, IN.
76 Product Information. Calquence (acalabrutinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
77 Kharasch ED, Thummel KE "Human alfentanil metabolism by cytochrome P450 3A3/4. An explanation for the interindividual variability in alfentanil clearance?" Anesth Analg 76 (1993): 1033-9. [PMID: 8484504]
78 Koehntop DE, Noormohamed SE, Fletcher CV "Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation." Pharmacotherapy 14 (1994): 592-9. [PMID: 7997393]
79 Labroo RB, Thummel KE, Kunze KL, Podoll T, Trager WF, Kharasch ED "Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism." Drug Metab Dispos 23 (1995): 490-6. [PMID: 7600917]
80 Kharasch ED, Russell M, Mautz D, Thummel KE, Kunze KL, Bowdle A, Cox K "The role of cytochrome P450 3A4 in alfentanil clearance. Implications for interindividual variability in disposition and perioperative drug interactions." Anesthesiology 87 (1997): 36-50. [PMID: 9232132]
81 Product Information. Piqray (alpelisib). Novartis Pharmaceuticals, East Hanover, NJ.
82 Product Information. Metvixia (methyl aminolevulinate topical). Galderma Laboratories Inc, Cranbury, NJ.
83 Acosta EP, Henry K, Baken L, Page LM, Fletcher CV "Indinavir concentrations and antiviral effect." Pharmacotherapy 19 (1999): 708-12. [PMID: 10391416]
84 Barry M, Gibbons S, Back D, Mulcahy F "Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations." Clin Pharmacokinet 32 (1997): 194-209. [PMID: 9084959]
85 Brooks J, Daily J, Schwamm L "Protease inhibitors and anticonvulsants." AIDS Clin Care 9 (1997): 87,90. [PMID: 11364776]
86 Canadian Pharmacists Association.
87 Hugen PWH, Burger DM, Brinkman K, terHofstede HJM, Schuurman R, Koopmans PP, Hekster YA "Carbamazepine-indinavir interaction causes antiretroviral therapy failure." Ann Pharmacother 34 (2000): 465-70. [PMID: 10772431]
88 Liedtke MD, Lockhart SM, Rathbun RC "Anticonvulsant and antiretroviral interactions." Ann Pharmacother 38 (2004): 482-9. [PMID: 14970370]
89 Product Information. Agenerase (amprenavir). Glaxo Wellcome, Research Triangle Pk, NC.
90 Product Information. Aptivus (tipranavir). Boehringer-Ingelheim, Ridgefield, CT.
91 Product Information. Crixivan (indinavir). Merck & Co, Inc, West Point, PA.
92 Product Information. Fortovase (saquinavir) Roche Laboratories, Nutley, NJ.
93 Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
94 Product Information. Lexiva (fosamprenavir). GlaxoSmithKline, Research Triangle Park, NC.
95 Product Information. Prezista (darunavir). Ortho Biotech Inc, Bridgewater, NJ.
96 Product Information. Reyataz (atazanavir). Bristol-Myers Squibb, Princeton, NJ.
97 Product Information. Viracept (nelfinavir). Agouron Pharma Inc, La Jolla, CA.
98 Sommadossi JP "HIV protease inhibitors: pharmacologic and metabolic distinctions." AIDS 13 (1999): s29-40. [PMID: 10546783]
99 Durant J, Clevenbergh P, Garraffo R, Halfon P, Icard S, DelGiudice P, Montagne N, Schapiro JM, Dellamonica P "Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study." Aids 14 (2000): 1333-9. [PMID: 10930147]
100 Ku LL, Ward CO, Durgin SJ "A clinical study of drug interaction and anticoagulant therapy." Drug Intell Clin Pharm 4 (1970): 300-6.
101 Okino K, Weibert RT "Warfarin-griseofulvin interaction." Drug Intell Clin Pharm 20 (1986): 291-3. [PMID: 3698827]
102 Wells PS, Holbrook AM, Crowther NR, Hirsh J "Interactions of warfarin with drugs and food." Ann Intern Med 121 (1994): 676-83. [PMID: 7944078]
103 Product Information. Eliquis (apixaban). Bristol-Myers Squibb Canada Inc, Montreal, IN.
104 Product Information. Otezla (apremilast). Celgene Corporation, Summit, NJ.
105 Product Information. Emend (aprepitant). Merck & Company Inc, West Point, PA.
106 Product Information. Emend for Injection (fosaprepitant). Merck & Company Inc, West Point, PA.
107 Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
108 Product Information. Nuvigil (armodafinil). Cephalon Inc, West Chester, PA.
109 Product Information. Provigil (modafinil). Cephalon, Inc, West Chester, PA.
110 Product Information. Coartem (artemether-lumefantrine). Novartis Pharmaceuticals, East Hanover, NJ.
111 Bullman J, Nicholls A, Van Landingham K, et al. "Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers." Epilepsia 52 (2011): 1351-8. [PMID: 21635243]
112 Gerber JG, Rosenkranz SL, Fichtenbaum CJ, et al. "Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study." J Acquir Immune Defic Syndr 39 (2005): 307-12. [PMID: 15980690]
113 Khandwala HM "Lipid lowering inefficacy of high-dose statin therapy due to concurrent use of phenytoin." South Med J 99 (2006): 1385-7. [PMID: 17233196]
114 Murphy MJ, Dominiczak MH "Efficacy of statin therapy: possible effect of phenytoin." Postgrad Med J 75 (1999): 359-60. [PMID: 10435174]
115 Product Information. Lipitor (atorvastatin). Parke-Davis, Morris Plains, NJ.
116 Product Information. Stendra (avanafil). Vivus Inc, Mountain View, CA.
117 Product Information. Ayvakit (avapritinib). Blueprint Medicines Corporation, Cambridge, MA.
118 Pithavala YK, Tortorici M, Toh M, et al "Effect of rifampin on the pharmacokinetics of axitinib (AG-013736) in Japanese and Caucasian healthy volunteers." Cancer Chemother Pharmacol 65 (2010): 563-70. [PMID: 19603168]
119 Product Information. Inlyta (axitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
120 Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
121 Bell J, Seres V, Bowron P, Lewis J, Batey R "The use of serum methadone levels in patients receiving methadone maintenance." Clin Pharmacol Ther 43 (1988): 623-9. [PMID: 3378383]
122 Liu S-J, Wang RI "Case report of barbiturate-induced enhancement of methadone metabolism and withdrawal syndrome." Am J Psychiatry 141 (1984): 1287-8. [PMID: 6486271]
123 Tong TG, Pond SM, Kreek MJ, et al "Phenytoin-induced methadone withdrawal." Ann Intern Med 94 (1981): 349-51. [PMID: 7224382]
124 Product Information. Biktarvy (bictegravir/emtricitabine/tenofovir). Gilead Sciences, Foster City, CA.
125 Product Information. Viread (tenofovir). Gilead Sciences, Foster City, CA.
126 Product Information. Incivek (telaprevir). Vertex Pharmaceuticals, Cambridge, MA.
127 Product Information. Victrelis (boceprevir). Schering-Plough Corporation, Kenilworth, NJ.
128 Product Information. Bosulif (bosutinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
129 Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
130 Product Information. Buprenex (buprenorphine). Reckitt and Colman Pharmaceutical, Richmond, VA.
131 Kivisto KT, Lamberg TS, Neuvonen PJ "Interactions of buspirone with itraconazole and rifampicin: Effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspirone." Pharmacol Toxicol 84 (1999): 94-7. [PMID: 10068153]
132 Lamberg TS, Kivisto KT, Neuvonen PJ "Concentrations and effects of buspirone are considerably reduced by rifampicin." Br J Clin Pharmacol 45 (1998): 381-5. [PMID: 9578186]
133 Product Information. Buspar (buspirone). Bristol-Myers Squibb, Princeton, NJ.
134 Altice FL, Friedland GH, Cooney EL "Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone." AIDS 13 (1999): 957-62. [PMID: 10371177]
135 Bending MR, Skacel PO "Rifampicin and methadone withdrawal." Lancet 1 (1977): 1211. [PMID: 68314]
136 Finelli PF "Phenytoin and methadone tolerance." N Engl J Med 294 (1976): 227. [PMID: 1244546]
137 Holmes VF "Rifampin-induced methadone withdrawal in AIDS." J Clin Psychopharmacol 10 (1991): 443-4. [PMID: 2286719]
138 Kreek MJ, Garfield JW, Gutjahr CL, Giusti LM "Rifampin-induced methadone withdrawal." N Engl J Med 294 (1976): 1104-6. [PMID: 1256526]
139 Otero MJ, Fuertes A, Sanchez R, Luna G "Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert." AIDS 13 (1999): 1004-5. [PMID: 10371190]
140 Pinzani V, Faucherre V, Peyriere H, Blayac JP "Methadone withdrawal symptoms with nevirapine and efavirenz." Ann Pharmacother 34 (2000): 405-7. [PMID: 10917395]
141 Product Information. Butorphanol Tartrate (butorphanol). Apotex Corporation, Weston, FL.
142 Product Information. Diskets (methadone). Cebert Pharmaceuticals Inc, Birmingham, AL.
143 Product Information. Duragesic Transdermal System (fentanyl). Janssen Pharmaceutica, Titusville, NJ.
144 Product Information. Ionsys (fentanyl). Ortho McNeil Pharmaceutical, Raritan, NJ.
145 Product Information. OxyContin (oxycodone). Purdue Frederick Company, Norwalk, CT.
146 Product Information. Zohydro ER (HYDROcodone). Zogenix, Inc, San Diego, CA.
147 Raistrick D, Hay A, Wolff K "Methadone maintenance and tuberculosis treatment." BMJ 313 (1996): 925-6. [PMID: 8876100]
148 Product Information. Jevtana (cabazitaxel). sanofi-aventis , Bridgewater, NJ.
149 Product Information. Cabometyx (cabozantinib). Exelixis Inc, S San Francisco, CA.
150 Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
151 Product Information. Tabrecta (capmatinib). Novartis Pharmaceuticals, East Hanover, NJ.
152 Benetello P, Furlanut M "Primidone-carbamazepine interaction: clinical consequences." Int J Clin Pharmacol Res 7 (1987): 165-8. [PMID: 3583497]
153 Eichelbaum M, Kothe KW, Hoffmann F, von Unruh GE "Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapy." Clin Pharmacol Ther 26 (1979): 366-71. [PMID: 466929]
154 Liu H, Delgado MR "Interactions of phenobarbital and phenytoin with carbamazepine and its metabolites' concentrations, concentration ratios, and level dose ratios in epileptic children." Epilepsia 36 (1995): 249-54. [PMID: 7614908]
155 Product Information. Tegretol (carbamazepine). Novartis Pharmaceuticals, East Hanover, NJ.
156 Ramsay RE, McManus DQ, Guterman A, et al "Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy." Ther Drug Monit 12 (1990): 235-41. [PMID: 2112276]
157 Spina E, Martines C, Fazio A, Trio R, Pisani F, Tomson T "Effect of phenobarbital on the pharmacokinetics of carbamazepine-10, 11-epoxide, an active metabolite of carbamazepine." Ther Drug Monit 13 (1991): 109-12. [PMID: 2053116]
158 Tomson T, Spina E, Wedlund JE "Minor additive inducing effects of phenobarbital on carbamazepine clearance in patients on combined carbamazepine-phenytoin therapy." Ther Drug Monit 9 (1987): 117-9. [PMID: 3576657]
159 Zielinski JJ, Haidukewych D "Dual effects of carbamazepine-phenytoin interaction." Ther Drug Monit 9 (1987): 21-3. [PMID: 3576659]
160 Product Information. Cancidas (caspofungin) Merck & Co, Inc, West Point, PA.
161 Product Information. Cotellic (cobimetinib). Genentech, South San Francisco, CA.
162 Product Information. Aliqopa (copanlisib). Bayer Pharmaceutical Inc, West Haven, CT.
163 Cerner Multum, Inc. "Canadian Product Information.".
164 Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
165 Product Information. Enablex (darifenacin). Novartis Pharmaceuticals, East Hanover, NJ.
166 Product Information. Nubeqa (darolutamide). Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ.
167 Borin MT, Chambers JH, Carel BJ, Gagnon S, Freimuth WW "Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate." Clin Pharmacol Ther 61 (1997): 544-53. [PMID: 9164416]
168 Product Information. Rescriptor (delavirdine). Pharmacia and Upjohn, Kalamazoo, MI.
169 Aronson JK, Grahame-Smith DG "Clinical pharmacology: adverse drug interactions." Br Med J 282 (1981): 288-91. [PMID: 6779990]
170 Baker SD "Drug interactions with the taxanes." Pharmacotherapy 17(5 Pt 2) (1997): s126-32. [PMID: 9322879]
171 Komoroski BJ, Parise RA, Egorin MJ, Strom SC, Venkataramanan R "Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures." Clin Cancer Res 11(19 Pt 1) (2005): 6972-9. [PMID: 16203790]
172 McInnes GT, Brodie MJ "Drug interactions that matter: a critical reappraisal." Drugs 36 (1988): 83-110. [PMID: 3063497]
173 Product Information. Taxotere (docetaxel). Rhone-Poulenc Rorer, Collegeville, PA.
174 Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
175 Product Information. Pifeltro (doravirine). Merck & Company Inc, Whitehouse Station, NJ.
176 EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
177 Product Information. Adriamycin PFS (doxorubicin). Pharmacia and Upjohn, Kalamazoo, MI.
178 Product Information. Doxil (doxorubicin liposomal). Sequis Pharmaceuticals Inc, Menlo Park, CA.
179 Kaytser V, Zhang P. Non-interacting, Non-opioid, and Non-barbiturate Containing Acute Medication Combinations in Headache: A Pilot Combinatorics Approach Based on DrugBank Database.?Front Neurol. 2021;12:632830. [PMID: 33679591]
180 Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
181 Product Information. Copiktra (duvelisib). Verastem, Inc., Needham, MA.
182 Marzolini C, Telenti A, Decosterd LA, Greub G, Biollaz J, Buclin T "Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients." Aids 15 (2001): 71-5. [PMID: 11192870]
183 Product Information. Orilissa (elagolix). AbbVie US LLC, North Chicago, IL.
184 Product Information. Zepatier (elbasvir-grazoprevir). Merck &amp Company Inc, Whitehouse Station, NJ.
185 Product Information. Cerdelga (eliglustat). Genzyme Corporation, Cambridge, MA.
186 Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
187 Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
188 Product Information. Xtandi (enzalutamide). Astellas Pharma US, Inc, Deerfield, IL.
189 Product Information. Tarceva (erlotinib). Genentech, South San Francisco, CA.
190 Product Information. Lunesta (eszopiclone). Sepracor Inc, Marlborough, MA.
191 Product Information. Intelence (etravirine). Ortho Biotech Inc, Bridgewater, NJ.
192 Product Information. Afinitor (everolimus). Novartis Pharmaceuticals, East Hanover, NJ.
193 Product Information. Aromasin (exemestane) Pharmacia & Upjohn, Kalamazoo, MI.
194 Product Information. Toviaz (fesoterodine). Pfizer U.S. Pharmaceuticals Group, New York, NY.
195 Product Information. Addyi (flibanserin). Sprout Pharmaceuticals, Raleigh, NC.
196 Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
197 Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
198 Product Information. Mavyret (glecaprevir-pibrentasvir). Abbott Pharmaceutical, Abbott Park, IL.
199 Kiechel JR, Lavene D, Guerret M, Comoy E, Godin M, Fillastre JP "Pharmacokinetic aspects of guanfacine withdrawal syndrome in a hypertensive patient with chronic renal failure." Eur J Clin Pharmacol 25 (1983): 463-6. [PMID: 6360692]
200 Product Information. Intuniv (guanfacine). Shire US Inc, Florence, KY.
201 Product Information. Imbruvica (ibrutinib). Pharmacyclics Inc, Sunnyvale, CA.
202 Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
203 Bolton AE, Peng B, Hubert M, et al. "Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects." Cancer Chemother Pharmacol 53 (2004): 102-6. [PMID: 14605865]
204 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
205 Product Information. Gleevec (imatinib mesylate). Novartis Pharmaceuticals, East Hanover, NJ.
206 Crews KR, Stewart CF, Jones-Wallace D, et al "Altered irinotecan pharmacokinetics in pediatric high-grade glioma patients receiving enzyme-inducing anticonvulsant therapy." Clin Cancer Res 8 (2002): 2202-9. [PMID: 12114421]
207 Di YM, Li CG, Xue CC, Zhou SF "Clinical drugs that interact with St. John's wort and implication in drug development." Curr Pharm Des 14 (2008): 1723-42. [PMID: 18673195]
208 Friedman HS, Petros WP, Friedman AH, et al "Irinotecan therapy in adults with recurrent or progressive malignant glioma." J Clin Oncol 17 (1999): 1516-25. [PMID: 10334539]
209 Innocenti F, Undevia SD, Ramirez J, et al. "A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital." Clin Pharmacol Ther 76 (2004): 490-502. [PMID: 15536463]
210 Kuhn JG "Influence of anticonvulsants on the metabolism and elimination of irinotecan. A North American Brain Tumor Consortium preliminary report." Oncology (Williston Park 16(8 Suppl 7) (2002): 33-40. [PMID: 12199631]
211 Hu ZP, Yang XX, Chen X, et al. A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort.?Curr Drug Metab. 2007;8(2):157-171. [PMID: 17305494]
212 Mathijssen RH, Verweij J, De Bruijn P, Loos WJ, Sparreboom A "Effects of St. John's Wort on Irinotecan Metabolism." J Natl Cancer Inst 94 (2002): 1247-9. [PMID: 12189228]
213 Minami H, Lad TE, Nicholas MK, Vokes EE, Ratain MJ "Pharmacokinetics and pharmacodynamics of 9-aminocamptothecin infused over 72 hours in phase II studies." Clin Cancer Res 5 (1999): 1325-30. [PMID: 10389915]
214 Murry DJ, Cherrick I, Salama V, et al. "Influence of phenytoin on the disposition of irinotecan: a case report." J Pediatr Hematol Oncol 24 (2002): 130-3. [PMID: 11990699]
215 Product Information. Camptosar (irinotecan). Pharmacia and Upjohn, Kalamazoo, MI.
216 Product Information. Onivyde (irinotecan liposomal). Merrimack Pharmaceuticals, Cambridge, MA.
217 Hofland KF, Hansen S, Sorensen M, et al. Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.?Acta Oncol. 2014;53(7):939-944. [PMID: 24456504]
218 Santos A, Zanetta S, Cresteil T, et al "Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans." Clin Cancer Res 6 (2000): 2012-20. [PMID: 10815927]
219 Yonemori K, Takeda Y, Toyota E, Kobayashi N, Kudo K "Potential interactions between irinotecan and rifampin in a patient with small-cell lung cancer." Int J Clin Oncol 9 (2004): 206-9. [PMID: 15221608]
220 Zamboni WC, Gajjar AJ, Heideman RL, et al "Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma." Clin Cancer Res 4 (1998): 783-9. [PMID: 9533548]
221 Product Information. Cresemba (isavuconazonium). Astellas Pharma US, Inc, Deerfield, IL.
222 Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
223 Product Information. Kalydeco (ivacaftor). Vertex Pharmaceuticals, Cambridge, MA.
224 Product Information. Orkambi (ivacaftor-lumacaftor). Vertex Pharmaceuticals, Cambridge, MA.
225 Product Information. Symdeko 4-Week (ivacaftor-tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
226 Product Information. Trikafta (elexacaftor/ivacaftor/tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
227 Product Information. Ixempra (ixabepilone). Bristol-Myers Squibb, Princeton, NJ.
228 Product Information. Ninlaro (ixazomib). Takeda Pharmaceuticals America, Lincolnshire, IL.
229 Product Information. Tykerb (lapatinib). Novartis Pharmaceuticals, East Hanover, NJ.
230 Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
231 Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
232 Product Information. Dayvigo (lemborexant). Eisai Inc, Woodcliff Lake, NJ.
233 Product Information. Tradjenta (linagliptin). Boehringer Ingelheim, Ridgefield, CT.
234 Product Information. Zokinvy (lonafarnib). Eiger BioPharmaceuticals, Palo Alto, CA.
235 Product Information. Latuda (lurasidone). Sunovion Pharmaceuticals Inc, Marlborough, MA.
236 Product Information. Zepzelca (lurbinectedin). Jazz Pharmaceuticals, Palo Alto, CA.
237 Product Information. Macrilen (macimorelin). Aeterna Zentaris, Charleston, SC.
238 Bruderer S, Aanismaa P, Homery MC, et al. "Effect of cyclosporine and rifampin on the pharmacokinetics of macitentan, a tissue-targeting dual endothelin receptor antagonist." AAPS J 14 (2012): 68-78. [PMID: 22189899]
239 Product Information. Opsumit (macitentan). Actelion Pharmaceuticals US Inc, South San Francisco, CA.
240 Product Information. Selzentry (maraviroc). Pfizer U.S. Pharmaceuticals Group, New York, NY.
241 Multum Information Services, Inc. Expert Review Panel.
242 Product Information. Oxsoralen (methoxsalen). ICN Pharmaceuticals Inc, Costa Mesa, CA.
243 Product Information. Uvadex (methoxsalen). Therakos Inc, Exton, PA.
244 Dutreix C, Munarini F, Lorenzo S, Roesel J, Wang Y "Investigation into CYP3A4-mediated drug-drug interactions on midostaurin in healthy volunteers." Cancer Chemother Pharmacol 72 (2013): 1223-34. [PMID: 24085261]
245 Product Information. Rydapt (midostaurin). Novartis Pharmaceuticals, East Hanover, NJ.
246 Product Information. Korlym (mifepristone). Corcept Therapeutics Incorporated, Menlo Park, CA.
247 Product Information. Mifeprex (mifepristone) Danco Laboratories, New York, NY.
248 Product Information. Singulair (montelukast). Merck & Co, Inc, West Point, PA.
249 Product Information. Movantik (naloxegol). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
250 Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
251 Product Information. Lynparza (olaparib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
252 Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
253 Jamis-Dow CA, Klecker RW, Katki AG, Collins JM "Metabolism of Taxol by human liver microsomes and effect of inhibitors (Meeting abstract)." Proc Annu Meet Am Assoc Cancer Res 34 (1993): a21981993.
254 Product Information. Abraxane (paclitaxel protein-bound). American Pharmaceutical Partners, Schaumberg, IL.
255 Product Information. Taxol (paclitaxel). Bristol-Myers Squibb, Princeton, NJ.
256 Spencer CM, Faulds D "Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer." Drugs 48 (1994): 794-847. [PMID: 7530632]
257 Product Information. Ibrance (palbociclib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
258 Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
259 Product Information. Votrient (pazopanib). GlaxoSmithKline, Research Triangle Park, NC.
260 Product Information. Pemazyre (pemigatinib). Incyte Corporation, Wilmington, DE.
261 Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
262 Product Information. Nuplazid (pimavanserin). Accelis Pharma, East Windsor, NJ.
263 Product Information. Iclusig (ponatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
264 Blakely KM, Drucker AM, Rosen CF "Drug-induced photosensitivity-an update: Culprit drugs, prevention and management." Drug Saf 42 (2019): 827-47. [PMID: 30888626]
265 Product Information. Photofrin (porfimer). Sanofi Winthrop Pharmaceuticals, New York, NY.
266 Bittencourt PR, Gracia CM, Martins R, et al "Phenytoin and carbamazepine decrease oral bioavailability of praziquantel." Neurology 42 (1992): 492-6. [PMID: 1549207]
267 Product Information. Biltricide (praziquantel). Bayer, West Haven, CT.
268 Ridtitid W, Wongnawa M, Mahatthanatrakul W, Punyo J, Sunbhanich M "Rifampin markedly decreases plasma concentrations of praziquantel in healthy volunteers." Clin Pharmacol Ther 72 (2002): 505-13. [PMID: 12426514]
269 Grimm SW, Richtand NM, Winter HR, Stams KR, Reele SB "Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics." Br J Clin Pharmacol 61 (2006): 58-69. [PMID: 16390352]
270 Product Information. Seroquel (quetiapine). Zeneca Pharmaceuticals, Wilmington, DE.
271 Quetiapine for schizophrenia. Med Lett Drugs Ther 39 (1997): 117-8. [PMID: 9422044]
272 Wong YWJ, Yeh C, Thyrum PT "The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine." J Clin Psychopharmacol 21 (2001): 89-93. [PMID: 11199955]
273 Fabre C, Criddle J, Nolder D, Klein JL "Recrudescence of imported falciparum malaria after quinine therapy: potential drug interaction with phenytoin." Trans R Soc Trop Med Hyg 99 (2005): 871-3. [PMID: 16099004]
274 Product Information. Qualaquin (quinine). AR Scientific Inc, Philadelphia, PA.
275 Product Information. Rifadin (rifampin). Hoechst Marion-Roussel Inc, Kansas City, MO.
276 Pukrittayakamee S, Prakongpan S, Wanwimolruk S, Clemens R, Looareesuwan S, White NJ "Adverse effect of rifampin on quinine efficacy in uncomplicated falciparum malaria." Antimicrob Agents Chemother 47 (2003): 1509-1513. [PMID: 12709315]
277 Twum-Barima Y, Carruthers SG "Quinidine-rifampin interaction." N Engl J Med 304 (1981): 1466-9. [PMID: 7231477]
278 Wanwimolruk S, Kang W, Coville PF, Viriyayudhakorn S, Thitiarchakul S "Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man." Br J Clin Pharmacol 40 (1995): 87-91. [PMID: 8527275]
279 Product Information. Rozerem (ramelteon). Takeda Pharmaceuticals America, Lincolnshire, IL.
280 Bidstrup TB, Bjornsdottir I, Sidelmann UG, Thomsen MS, Hansen KT "CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide." Br J Clin Pharmacol 56 (2003): 305-14. [PMID: 12919179]
281 Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivisto KT "Rifampin decreases the plasma concentrations and effects of repaglinide." Clin Pharmacol Ther 68 (2000): 495-500. [PMID: 11103752]
282 Product Information. Prandin (repaglinide). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
283 Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
284 Product Information. Edurant (rilpivirine). Tibotec Pharmaceuticals, Titusville, NJ.
285 Product Information. Qinlock (ripretinib). Deciphera Pharmaceuticals, Waltham, MA.
286 Product Information. Xarelto (rivaroxaban). Bayer Inc, Toronto, IA.
287 Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
288 Product Information. Jakafi (ruxolitinib). Incyte Corporation, Wilmington, DE.
289 Product Information. Onglyza (saxagliptin). Bristol-Myers Squibb, Princeton, NJ.
290 Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
291 Product Information. Koselugo (selumetinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
292 Product Information. Rapaflo (silodosin). Watson Pharmaceuticals, Corona, CA.
293 Product Information. Prograf (tacrolimus). Fujisawa, Deerfield, IL.
294 Product Information. Rapamune (sirolimus) Wyeth-Ayerst Laboratories, Philadelphia, PA.
295 Product Information. VESIcare (solifenacin). GlaxoSmithKline, Research Triangle Park, NC.
296 Product Information. Odomzo (sonidegib). Novartis Pharmaceuticals, East Hanover, NJ.
297 Product Information. Diacomit (stiripentol). Biocodex Inc, Creswell, OR.
298 Product Information. Sutent (sunitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
299 Product Information. Belsomra (suvorexant). Merck & Company Inc, Whitehouse Station, NJ.
300 Product Information. Adcirca (tadalafil). United Therapeutics Corporation, Silver Spring, MD.
301 Product Information. Cialis (tadalafil). Lilly, Eli and Company, Indianapolis, IN.
302 Biochem Pharmacol "Variable contribution of cytochromes P450 2D6, 2C9, and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes." Biochem Pharmacol 53 (1997): 171-8. [PMID: 9037249]
303 Kivisto KT, Villikka K, Nyman L, Anttila M, Neuvonen PJ "Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin." Clin Pharmacol Ther 64 (1998): 648-54. [PMID: 9871429]
304 Lien EA, Anker G, Lonning PE, et al "Decreased serum concentrations of tamoxifen and its metabolites induced by aminoglutethimide." Cancer Res 50 (1990): 5851-7. [PMID: 2393854]
305 Product Information. Targretin (bexarotene) Ligand Pharmaceuticals, San Diego, CA.
306 Product Information. Hetlioz (tasimelteon). Vanda Pharmaceuticals Inc, Rockville, MD.
307 Product Information. Tazverik (tazemetostat). Epizyme, Inc, Cambridge, MA.
308 Product Information. Ketek (telithromycin). Aventis Pharmaceuticals, Bridgewater, NJ.
309 European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products "European Public Assessment Report Ketek (telithromycin) (Rev. 2) ".
310 Product Information. Torisel (temsirolimus). Wyeth-Ayerst Laboratories, Philadelphia, PA.
311 Product Information. Brilinta (ticagrelor). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
312 Teng R, Mitchell P, Butler K "Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects." Eur J Clin Pharmacol 69 (2013): 877-83. [PMID: 23093043]
313 Weeks P, Sieg A, Vahdat K, Raissi F, Nathan S "Improved ticagrelor antiplatelet effect on discontinuation of phenytoin." Ann Pharmacother 48 (2014): 644-7. [PMID: 24477376]
314 Product Information. Xeljanz (tofacitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
315 Product Information. Samsca (tolvaptan). Otsuka American Pharmaceuticals Inc, Rockville, MD.
316 Berthou F, Dreano Y, Belloc C, Kangas L, Gautier JC, Beaune P "Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes." Biochem Pharmacol 47 (1994): 1883-95. [PMID: 8204106]
317 Product Information. Fareston (toremifene). Schering Laboratories, Kenilworth, NJ.
318 Machiels JP, Staddon A, Herremans C, et al. "Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studies." Cancer Chemother Pharmacol 74 (2014): 729-37. [PMID: 25100135]
319 Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
320 Product Information. Tukysa (tucatinib). Seattle Genetics Inc, Bothell, WA.
321 Product Information. Ubrelvy (ubrogepant). Allergan Inc, Irvine, CA.
322 Product Information. ella (ulipristal). Afaxys Inc., Charleston, SC.
323 Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
324 Product Information. Venclexta (venetoclax). AbbVie US LLC, North Chicago, IL.
325 Product Information. Marqibo (vinCRIStine liposome). Talon Therapeutics Inc, South San Francisco,, CA.
326 Product Information. VFEND (voriconazole). Pfizer U.S. Pharmaceuticals, New York, NY.
327 Product Information. Brintellix (vortioxetine). Takeda Pharmaceuticals America, Lincolnshire, IL.
328 Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
329 Product Information. Ambien (zolpidem). sanofi-aventis, Bridgewater, NJ.
330 Villikka K, Kivisto KT, Luurila H, Neuvonen PJ "Rifampin reduces plasma concentrations and effects of zolpidem." Clin Pharmacol Ther 62 (1997): 629-34. [PMID: 9433391]
331 Vlase L, Popa A, Neag M, Muntean D, Baldea I, Leucuta SE "Pharmacokinetic Interaction Between Zolpidem and Carbamazepine in Healthy Volunteers." J Clin Pharmacol (2010):. [PMID: 21098143]
332 Nakasa H, Nakamura H, Ono S, Tsutsui M, Kiuchi M, Ohmori S, Kitada M "Prediction of drug-drug interactions of zonisamide metabolism in humans from in vitro data." Eur J Clin Pharmacol 54 (1998): 177-83. [PMID: 9626925]
333 Product Information. Zonegran (zonisamide) Elan Pharmaceuticals, S. San Francisco, CA.
334 Product Information. Lariam (mefloquine). Roche Laboratories, Nutley, NJ.
335 Product Information. Remeron (mirtazapine). Organon, West Orange, NJ.
336 Sitsen JM, Maris FA, Timmer CJ "Drug-drug interaction studies with mirtazapine and carbamazepine in healthy male subjects." Eur J Drug Metab Pharmacokinet 26 (2001): 109-21. [PMID: 11554425]
337 Spaans E, Van Den Heuvel MW, Schnabel PG, et al. "Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects." Eur J Clin Pharmacol 58 (2002): 423-9. [PMID: 12242602]
338 Timmer CJ, Sitsen JMA, Delbressine LP "Clinical pharmacokinetics of mirtazapine." Clin Pharmacokinet 38 (2000): 461-74. [PMID: 10885584]
339 Hyland R, Roe GH, Jones BC, Smith DA "Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil." Br J Clin Pharmaacol 51 (2001): 239-48. [PMID: 11298070]
340 Product Information. Revatio (sildenafil). Pfizer U.S. Pharmaceuticals Group, New York, NY.
341 Product Information. Viagra (sildenafil). Pfizer US Pharmaceuticals, New York, NY.
342 Warrington JS, Shader RI, vonMoltke LL, Greenblatt DJ "In vitro biotransformation of sildenafil (Viagra): Identification of human cytochromes and potential drug interactions." Drug Metab Disposition 28 (2000): 392-7. [PMID: 10725306]
343 Product Information. Nexavar (sorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
344 Hellmann A, Rule S, Walewski J, et al. "Effect of cytochrome P450 3A4 inducers on the pharmacokinetic, pharmacodynamic and safety profiles of bortezomib in patients with multiple myeloma or Non-Hodgkin's lymphoma." Clin Pharmacokinet 50 (2011): 781-91. [PMID: 22087865]
345 Pekol T, Daniels JS, Labutti J, et al "Human metabolism of the proteasome inhibitor bortezomib: identification of circulating metabolites." Drug Metab Dispos 33 (2005): 771-7. [PMID: 15764713]
346 Product Information. Velcade (bortezomib). Millennium Pharmaceuticals Inc, Cambridge, MA.
347 Uttamsingh V, Lu C, Miwa GT, Gan LS "Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4 to the hepatic metabolism of teh protosome inhibitor bortezomib." Drug Metab Dispos 33 (2005): 1723-8. [PMID: 16103134]
348 Product Information. Evoxac (cevimeline) Daiichi Pharmaceuticals, Fort lee, NJ.
349 Product Information. Aczone (dapsone topical). QLT USA, Inc, Fort Collins, CO.
350 Phillips KR, Wideman SD, Cochran EB, Becker JA "Griseofulvin significantly decreases serum salicylate concentrations." Pediatr Infect Dis J 12 (1993): 350-2. [PMID: 8483633]
351 Product Information. Persantine (dipyridamole). Boehringer-Ingelheim, Ridgefield, CT.
352 Ranhosky A, Kempthorne-Rawson J, the Intravenous Dipyridamole Thallium Imaging Study Group "The safety of intravenous dipyridamole thallium myocardial perfusion imaging." Circulation 81 (1990): 1205-9. [PMID: 2107985]
353 Product Information. Tivicay (dolutegravir). ViiV Healthcare, Research Triangle Park, NC.
354 Product Information. Rukobia (fostemsavir). ViiV Healthcare, Research Triangle Park, NC.
355 Product Information. Chirocaine (levobupivacaine) Organon, West Orange, NJ.
356 Product Information. Victoza (liraglutide). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
357 Product Information. Myrbetriq (mirabegron). Astellas Pharma US, Inc, Deerfield, IL.
358 Heinonen J, Takki S, Jarho L "Plasma lidocaine levels in patients treated with potential inducers of microsomal enzymes." Acta Anaesthesiol Scand 14 (1970): 89-95. [PMID: 5428253]
359 Perucca E, Richens A "Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients." Br J Clin Pharmacol 8 (1979): 21-31. [PMID: 552293]
360 Perucca E, Ruprah M, Richens A, Park BK, Betteridge DJ, Hedges AM "Effect of low-dose phenobarbitone on five indirect indices of hepatic microsomal enzyme induction and plasma lipoproteins in normal subjects." Br J Clin Pharmacol 12 (1981): 592-6. [PMID: 6117310]
361 Reichel C, Skodra T, Nacke A, Spengler U, Sauerbruch T "The lignocaine metabolite (MEGX) liver function test and P-450 induction in humans." Br J Clin Pharmacol 46 (1998): 535-9. [PMID: 9862241]
362 Miceli JJ, Anziano RJ, Robarge L, Hansen RA, Laurent A "The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers." Br J Clin Pharmacol 49(suppl 1) (2000): s65-70. [PMID: 10771457]
363 Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.